|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61B 5/145 | (2006.01) |
| G05B 13/048 | (2013.01) | ||
| A61B 5/00 | (2006.01) | ||
| A61B 5/7275 | (2013.01) | ||
| G05B 13/04 | (2006.01) | ||
| G16H 50/20 | (2018.01) | ||
| A61B 5/14532 | (2013.01) | ||
| G16H 20/17 | (2018.01) |
| (11) | Number of the document | 3618713 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18729226.3 |
| Date of filing the European patent application | 2018-05-03 | |
| (97) | Date of publication of the European application | 2020-03-11 |
| (45) | Date of publication and mention of the grant of the patent | 2021-12-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/030771 |
| Date | 2018-05-03 |
| (87) | Number | WO 2018/204568 |
| Date | 2018-11-08 |
| (30) | Number | Date | Country code |
| 201762501976 P | 2017-05-05 | US | |
| 201762536541 P | 2017-07-25 | US |
| (72) |
HAIDAR, Ahmad Mohamad , US
|
| (73) |
Eli Lilly and Company ,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | CLOSED LOOP CONTROL OF PHYSIOLOGICAL GLUCOSE |
| CLOSED LOOP CONTROL OF PHYSIOLOGICAL GLUCOSE |